• CEO Lee Sung Joo bought 10,000 Orum Therapeutics common shares on October 23, 2026, at 17,176 won each.
• His holdings increased to 3,398,000 shares as of October 29, 2026.
• His stake fell to 14.55% from 16.19% in the February 21, 2025, disclosure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orum Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261029000440), on October 29, 2026, and is solely responsible for the information contained therein.